These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17227540)

  • 41. Penile ulceration: a rare manifestation of cutaneous crohn's successfully treated with subcutaneous methotrexate.
    Bajaj V; Sripathy TK; Ralph S
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e87-e88. PubMed ID: 26373246
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
    Nørgård B; Pedersen L; Christensen LA; Sørensen HT
    Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reply: To PMID 23333660.
    Seinen ML; De Boer NK; van Bodegraven AA
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1039. PubMed ID: 23669208
    [No Abstract]   [Full Text] [Related]  

  • 44. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
    Meier J; Sturm A
    Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
    [No Abstract]   [Full Text] [Related]  

  • 45. Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease?
    Weersma RK; Batstra MR; Kleibeuker JH; van Dullemen HM
    JOP; 2008 May; 9(3):283-9. PubMed ID: 18469440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adalimumab: new indication. Severe Crohn's disease: a second TNF alpha antagonist, subcutaneous administration.
    Prescrire Int; 2008 Aug; 17(96):137. PubMed ID: 19480092
    [No Abstract]   [Full Text] [Related]  

  • 47. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ; Feagan BG; Lichtenstein GR
    Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methotrexate for recalcitrant cutaneous Crohn's disease: a dermatology-based case series with emphasis on outcomes.
    Hrin ML; Williams J; Bowers NL; Ahn CS; Strowd LC
    Int J Dermatol; 2023 Apr; 62(4):e274-e276. PubMed ID: 36040019
    [No Abstract]   [Full Text] [Related]  

  • 49. Crohn's disease: current treatment options.
    Akobeng AK
    Arch Dis Child; 2008 Sep; 93(9):787-92. PubMed ID: 18456695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevention of post-surgical recurrence of Crohn's disease. A perspective].
    Paviotti A; Terrosu G; Avellini C; Girometti R; Sorrentino D
    Recenti Prog Med; 2009 May; 100(5):233-8. PubMed ID: 19772213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
    [No Abstract]   [Full Text] [Related]  

  • 52. Experiences with a long-term treatment of a massive gluteal acne inversa with infliximab in Crohn's disease.
    Goertz RS; Konturek PC; Naegel A; Janka R; Amann K; Maennlein G; Wein A; Hahn EG; Boxberger F
    Med Sci Monit; 2009 Jan; 15(1):CS14-8. PubMed ID: 19114971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fatal bone marrow aplasia after the 1st injection of methotrexate in a woman with Crohn's disease].
    Bellaïche G; Maisonneuve L; Nouts A; Ley G; Slama JL
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1102-3. PubMed ID: 10592889
    [No Abstract]   [Full Text] [Related]  

  • 54. [Azathioprine for prevention of postoperative recurrence in Crohn's disease].
    Abdelli MN; Ben Abdallah H; Houissa F; Bouali MR; Khediri MF
    Tunis Med; 2007 Jul; 85(7):569-72. PubMed ID: 18064988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crohn's disease, relapsing polychondritis and epidermolysis bullosa acquisita: an immune-mediated inflammatory syndrome.
    Vicente EF; Hernández-Núñez A; Aspa J; Aragües M; García-Vicuña R
    Rheumatology (Oxford); 2008 Mar; 47(3):380-1. PubMed ID: 18238795
    [No Abstract]   [Full Text] [Related]  

  • 56. Usefulness of an elemental diet in Crohn's disease.
    Takahashi H; Ando T; Watanabe O; Maeda O; Ishiguro K; Ohmiya N; Niwa Y; Goto H
    Inflammopharmacology; 2007 Feb; 15(1):15-7. PubMed ID: 17323189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pregnancy and breastfeeding in patients with Crohn's disease.
    Mottet C; Juillerat P; Pittet V; Gonvers JJ; Froehlich F; Vader JP; Michetti P; Felley C
    Digestion; 2007; 76(2):149-60. PubMed ID: 18239407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural history of pediatric Crohn's disease: a population-based cohort study.
    Vernier-Massouille G; Balde M; Salleron J; Turck D; Dupas JL; Mouterde O; Merle V; Salomez JL; Branche J; Marti R; Lerebours E; Cortot A; Gower-Rousseau C; Colombel JF
    Gastroenterology; 2008 Oct; 135(4):1106-13. PubMed ID: 18692056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mucosal healing in Crohn disease].
    Jałocha L; Wojtuń S; Dyrla P; Blaszak A; Wojtkowiak M; Zysko B; Gil J
    Pol Merkur Lekarski; 2009 May; 26(155):554-5. PubMed ID: 19606724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The frequency of sister chromatid exchanges in patients with Crohn's disease and the effect of therapy with "anti-tumor necrosis factor" on this frequency.
    Danalioglu A
    Hepatogastroenterology; 2009; 56(91-92):729-33. PubMed ID: 19621692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.